Regarding functional well-differentiated G1-G2 neuroendocrine tumors (NETs) (mitotic rate: ≤20, Ki-67: ≤20%) with liver metastases, a population-based study concluded that resection of the primary tumor improves survival outcomes [58]. This evidence concerns the gene MKI67 and neuroendocrine neoplasm.